Tardive Dyskinesia 360°

Tardive Dyskinesia 360°

On-Demand Webcast
PROGRAM DESCRIPTION

This activity was developed for psychiatrists, primary care physicians, psychologists, nurse practitioners, physician assistances, psychiatric nurses, and other healthcare professionals who seek to improve the care of patients with tardive dyskinesia.

Tardive dyskinesia (TD), a syndrome characterized by hyperkinetic and abnormal involuntary movements, imposes devastating effects on a patient’s quality of life and negatively impacts daily function and social well-being. Symptoms are rarely reversible, with a cumulative risk incurred by the extent of antipsychotic treatment duration. This session brings together a psychiatrist and a neurologist to discuss the challenges of diagnosing and treating patients with TD. These experts will review the latest data on current and recently approved treatments for TD and demonstrate how to incorporate that information into everyday clinical practice through an interactive, live-patient case presentation.

WEBCAST ACCESS

CLICK HERE to access the webcast and for complete accreditation information.

This activity is hosted on the Medscape website. Viewers will need to create an account before accessing the webcast. Please visit www.medscape.org or the above access link for more information.

FACULTY

Rakesh Jain, MD
Clinical Professor
Department of Psychiatry
Texas Tech University School of Medicine
Austin, Texas

Rajeev Kumar, MD
Medical Director
Rocky Mountain Movement Disorders Center
Huntington’s Disease Society of America Center of Excellence
Colorado Neurological Institute
Englewood, Colorado

ACCREDITATION INFORMATION

In support of improving patient care, North American Center for Continuing Medical Education, LLC (NACCME) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

CME

NACCME designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE

This continuing nursing education activity awards 1.5 contact hours.

Provider approved by the California Board of Registered Nursing, Provider #13255 for 1.5 contact hours.

GRANT SUPPORT

Supported by educational grants from Neurocrine Biosciences and Teva Pharmaceuticals.